Symbolbild · KI-generiert
Moss Genomics Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Moss Genomics is a biotechnology company focused on genomics and microbiome research to develop advanced genetic insights and solutions. The company leverages blockchain technology to enhance security and user control over genomic information. Along with its genomics-focused products, Moss Genomics deploys an Ethereum accumulation strategy as part of its treasury management, currently holding 160 ETH on its balance sheet.
Company description as published by the issuer via Canadian Securities Exchange.
Comparable companies
Companies in the Industrials & Manufacturing sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Moss Genomics Inc. | MOSS | CSE | 1 Mio. USD |
| Tempus Capital Inc. | TEMP | CSE | 1 Mio. USD |
| Copland Road Capital Corporation | CRCC | CSE | 1 Mio. USD |
| Urban Infrastructure Group Inc. | UIG | TSXV | 1 Mio. USD |
| Doseology Sciences Inc | MOOD | CSE | 1 Mio. USD |
| First Growth Funds Limited | FGFL | CSE | 1 Mio. USD |
| Spectra Products Inc. | SSA | TSXV | 2 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.